Leukemia & Lymphoma, Volume 56, Issue 7 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 7 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries on selected article in this issue

Article Commentary
Follicular lymphoma: is peripheral blood involvement still an adverse prognostic factor in the rituximab era?
Estella Matutes, John F. Seymour & Aaron Polliack
Pages: 1919-1921
Published online: 21 Jan 2015
First Page PreviewforFollicular lymphoma: is peripheral blood involvement still an adverse prognostic factor in the rituximab era? | Full Text | References | PDF (128.9 KB) | Supplemental
  • 246 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Predicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failure
Jason B. Kaplan, Leonidas C. Platanias & Francis J. Giles
Pages: 1922-1923
Published online: 21 Jan 2015
CitationforPredicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failure | Full Text | References | PDF (122.8 KB) | Supplemental
  • 198 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
EZH2: a potential new target in T-cell lymphoma?
Lisa Giulino-Roth
Pages: 1924-1925
Published online: 14 Feb 2015
CitationforEZH2: a potential new target in T-cell lymphoma? | Full Text | References | PDF (118.8 KB) | Supplemental
  • 338 Views
  • 3 CrossRef citations
  • 0Altmetric
Article Commentary
Hedgehog inhibition as monotherapy in myelofibrosis: is there any role?
Aparna Kalyan & Brady L. Stein
Pages: 1926-1927
Published online: 30 Mar 2015
CitationforHedgehog inhibition as monotherapy in myelofibrosis: is there any role? | Full Text | References | PDF (127.4 KB) | Supplemental
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
BCL2 inhibition in double hit lymphoma
Mary Ann Anderson, David C. S. Huang & Andrew W. Roberts
Pages: 1928-1929
Published online: 21 Jan 2015
CitationforBCL2 inhibition in double hit lymphoma | Full Text | References | PDF (125.4 KB) | Supplemental
  • 343 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review Article
Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma
Umar Farooq & Ginna G. Laport
Pages: 1930-1937
Published online: 20 Nov 2014
AbstractforRecent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma | Full Text | References | PDF (177.6 KB) | Supplemental
  • 765 Views
  • 4 CrossRef citations
  • 0Altmetric
Review Article
Novel insights into the biology and treatment of chronic myeloproliferative neoplasms
Tariq I. Mughal, Tiziano Barbui, Omar Abdel-Wahab, Robert Kralovics, Catriona Jamieson, Hans-Michael Kvasnicka, Ann Mullaly, Raajit Rampal, Ruben Mesa, Jean-Jacques Kiladjian, Michael Deininger, Josef Prchal, Rüdiger Hehlmann, Giuseppe Saglio & Richard A. Van Etten
Pages: 1938-1948
Published online: 19 Nov 2014
AbstractforNovel insights into the biology and treatment of chronic myeloproliferative neoplasms | Full Text | References | PDF (2.6 MB) | Supplemental
  • 827 Views
  • 3 CrossRef citations
  • 0Altmetric
Review Article
Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy
Krzysztof Jamroziak, Tamar Tadmor, Tadeusz Robak & Aaron Polliack
Pages: 1949-1958
Published online: 21 Jan 2015
AbstractforRichter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy | Full Text | References | PDF (7.5 MB) | Supplemental
  • 1939 Views
  • 39 CrossRef citations
  • 0Altmetric
Review Article
Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era
Clémentine Sarkozy, Vincent Camus, Hervé Tilly, Gilles Salles & Fabrice Jardin
Pages: 1959-1968
Published online: 21 Jan 2015
AbstractforBody mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era | Full Text | References | PDF (2.2 MB) | Supplemental
  • 762 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Recurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents
Antonello Pinto, Paolo Corradini, Alberto Mussetti & Pier Luigi Zinzani
Pages: 1969-1974
Published online: 04 Dec 2014
AbstractforRecurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents | Full Text | References | PDF (161.9 KB) | Supplemental
  • 402 Views
  • 2 CrossRef citations
  • 0Altmetric
Review Article
The transcription factor ETS1 in lymphomas: friend or foe?
Monica Testoni, Elaine Yee Lin Chung, Valdemar Priebe & Francesco Bertoni
Pages: 1975-1980
Published online: 14 Jan 2015
AbstractforThe transcription factor ETS1 in lymphomas: friend or foe? | Full Text | References | PDF (489.8 KB) | Supplemental
  • 736 Views
  • 11 CrossRef citations
  • 0Altmetric
Review Article
Tumor suppressors in follicular lymphoma
Cassandra Graham & David P. LeBrun
Pages: 1981-1988
Published online: 14 Jan 2015
AbstractforTumor suppressors in follicular lymphoma | Full Text | References | PDF (331.7 KB) | Supplemental
  • 370 Views
  • 4 CrossRef citations
  • 0Altmetric
Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors
Ruben A. Mesa, Robyn M. Scherber & Holly L. Geyer
Pages: 1989-1999
Published online: 17 Mar 2015
AbstractforReducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors | Full Text | References | PDF (309.5 KB) | Supplemental
  • 782 Views
  • 21 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Clinicopathological characteristics of follicular lymphoma with peripheral blood involvement
Akiko Miyagi Maeshima, Hirokazu Taniguchi, Kensaku Tanioka, Hideaki Kitahara, Ken-Ichi Miyamoto, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Yukio Kobayashi, Kensei Tobinai & Ryoji Kushima
Pages: 2000-2004
Published online: 14 Nov 2014
AbstractforClinicopathological characteristics of follicular lymphoma with peripheral blood involvement | Full Text | References | PDF (9.2 MB) | Supplemental
  • 479 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
Karen Juul Mylam, Lale Kostakoglu, Martin Hutchings, Morton Coleman, Dominick Lamonica, Myron S. Czuczman, Louis F. Diehl, Anne L. Nielsen, Paw Jensen, Annika Loft, Helle W. Hendel, Victor Iyer, Sirpa Leppä, Sirkku Jyrkkiö, Harald Holte, Mikael Eriksson, Dorte Gillstrøm, Per B. Hansen, Marko Seppänen, Karin Hjorthaug, Peter de Nully Brown & Lars M. Pedersen
Pages: 2005-2012
Published online: 20 Nov 2014
Abstractfor18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study | Full Text | References | PDF (614.6 KB) | Supplemental
  • 431 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Ten years’ experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study
David Belada, Pavla Štěpánková, Alice Sýkorová, Pavel Žák & Lukáš Smolej
Pages: 2013-2018
Published online: 10 Feb 2015
AbstractforTen years’ experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study | Full Text | References | PDF (208.4 KB) | Supplemental
  • 238 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma
Suzanne Sachsman, Bradford S. Hoppe, Nancy P. Mendenhall, Adam Holtzman, Zuofeng Li, William Slayton, Mike Joyce, Eric Sandler & Stella Flampouri
Pages: 2019-2024
Published online: 19 Nov 2014
AbstractforProton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma | Full Text | References | PDF (897.2 KB) | Supplemental
  • 266 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study
Isabelle Fleury, Sandy Amorim, Nicolas Mounier, Bertrand Coiffier, Jehan Dupuis, Hervè Tilly, Mohamed A. Mazari, Lauriane Filliatre, Josette Brière, Pauline Brice, Eric de Kerviler & Catherine Thieblemont
Pages: 2025-2031
Published online: 17 Dec 2014
AbstractforManagement and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study | Full Text | References | PDF (227 KB) | Supplemental
  • 676 Views
  • 4 CrossRef citations
  • 0Altmetric
Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
Bhumsuk Keam, Hyerim Ha, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim & Dae Seog Heo
Pages: 2032-2038
Published online: 21 Jan 2015
AbstractforNeutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone | Full Text | References | PDF (2.9 MB) | Supplemental
  • 557 Views
  • 36 CrossRef citations
  • 0Altmetric
Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma
Anne O. Gang, Mette Ø. Pedersen, Helle Knudsen, Anne F. Lauritzen, Michael Pedersen, Signe L. Nielsen, Peter Brown, Estrid Høgdall, Tobias W. Klausen & Peter Nørgaard
Pages: 2039-2046
Published online: 21 Jan 2015
AbstractforCell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma | Full Text | References | PDF (656.4 KB) | Supplemental
  • 419 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era
Chieh-Sheng Lu, Jia-Hong Chen, Tzu-Chuan Huang, Yi-Ying Wu, Ping-Ying Chang, Ming-Shen Dai, Yeu-Chin Chen & Ching-Liang Ho
Pages: 2047-2055
Published online: 14 Jan 2015
AbstractforDiffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era | Full Text | References | PDF (554.3 KB) | Supplemental
  • 407 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Clinical significance of reduced SFRP1 expression in acute myeloid leukemia
Cui An, Hong Guo, Xiang-mei Wen, Chun-yan Tang, Jing Yang, Xiao-wen Zhu, Jia-yu Yin, Qing Liu, Ji-chun Ma, Zhao-qun Deng, Jiang Lin & Jun Qian
Pages: 2056-2060
Published online: 19 Nov 2014
AbstractforClinical significance of reduced SFRP1 expression in acute myeloid leukemia | Full Text | References | PDF (291.8 KB) | Supplemental
  • 136 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
Ryan Mattison, Alcee Jumonville, Patrick James Flynn, Alvaro Moreno-Aspitia, Charles Erlichman, Betsy LaPlant & Mark B. Juckett
Pages: 2061-2066
Published online: 19 Nov 2014
AbstractforA phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome | Full Text | References | PDF (350.9 KB) | Supplemental
  • 250 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis
Chul Won Jung, Lee-Yung Shih, Zhijian Xiao, Jin Jie, Hsin-An Hou, Xin Du, Ming-Chung Wang, Seonyang Park, Ki-Seong Eom, Kenji Oritani, Shinichiro Okamoto, Tetsuzo Tauchi, Jin Seok Kim, Daobin Zhou, Shigeki Saito, Junmin Li, Hiroshi Handa, Li Jianyong, Kohshi Ohishi, Ming Hou, Wu Depei, Katsuto Takenaka, Ting Liu, Yu Hu, Taro Amagasaki, Kazuo Ito, Prashanth Gopalakrishna & Koichi Akashi
Pages: 2067-2074
Published online: 20 Nov 2014
AbstractforEfficacy and safety of ruxolitinib in Asian patients with myelofibrosis | Full Text | References | PDF (268 KB) | Supplemental
  • 3899 Views
  • 23 CrossRef citations
  • 0Altmetric
Open Access
Article
Patients with Philadelphia-positive leukemia with Y253H or F359V mutation have a high risk of developing new mutations in the setting of dasatinib resistance
Qian Jiang, Ya-Zhen Qin, Yue-Yun Lai, Hao Jiang, Jing Wang & Xiao-Jun Huang
Pages: 2075-2081
Published online: 14 Jan 2015
AbstractforPatients with Philadelphia-positive leukemia with Y253H or F359V mutation have a high risk of developing new mutations in the setting of dasatinib resistance | Full Text | References | PDF (187 KB) | Supplemental
  • 392 Views
  • 2 CrossRef citations
  • 0Altmetric
Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation
Nora Oliver, Briana Short, Mya Thein, Vu H. Duong, Michael L. Tidwell, Edward A. Sausville, Maria R. Baer, Farin Kamangar & Ashkan Emadi
Pages: 2082-2086
Published online: 14 Jan 2015
AbstractforTreatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation | Full Text | References | PDF (230.1 KB) | Supplemental
  • 305 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases
Min Shi, Ali Shahsafaei, Cuiling Liu, Hongbo Yu & David M. Dorfman
Pages: 2087-2091
Published online: 30 Oct 2014
AbstractforEnhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases | Full Text | References | PDF (865.3 KB) | Supplemental
  • 358 Views
  • 19 CrossRef citations
  • 0Altmetric
Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis
Koji Sasaki, Jason R. Gotlib, Ruben A. Mesa, Kate J. Newberry, Farhad Ravandi, Jorge E. Cortes, Patrick Kelly, Jeffery L. Kutok, Hagop M. Kantarjian & Srdan Verstovsek
Pages: 2092-2097
Published online: 17 Feb 2015
AbstractforPhase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis | Full Text | References | PDF (514.7 KB) | Supplemental
  • 380 Views
  • 44 CrossRef citations
  • 0Altmetric
Article
Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care
Arno P. M. Mank, Charlot Schoonenberg, Kim Bleeker, Susanne Heijmenberg, Koen de Heer, Marinus H. J. van Oers & Marie José Kersten
Pages: 2098-2104
Published online: 23 Jul 2015
AbstractforEarly discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care | Full Text | References | PDF (259.6 KB) | Supplemental
  • 369 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia
Jaspal Kaeda, Frauke Ringel, Christian Oberender, Ken Mills, Concetta Quintarelli, Fabrizio Pane, Steffen Koschmieder, Robert Slany, Rolf Schwarzer, Giuseppe Saglio, Philipp Hemmati, Antje van Lessen, Leila Amini, Martin Gresse, Elisabetta Vagge, Thomas Burmeister, Anna Serra, Anne Carson, Michaela Schwarz, Jörg Westermann, Franziska Jundt, Bernd Dörken & Philipp le Coutre
Pages: 2105-2113
Published online: 23 Jan 2015
AbstractforUp-regulated MSI2 is associated with more aggressive chronic myeloid leukemia | Full Text | References | PDF (1 MB) | Supplemental
  • 427 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection
Laura K. Fogli, Michael E. Williams, Joseph M. Connors, Yvonne Reid, Kathleen Brown & Owen A. O’Connor
Pages: 2114-2122
Published online: 11 Feb 2015
AbstractforDevelopment and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection | Full Text | References | PDF (1.4 MB) | Supplemental
  • 345 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies
Alejandra Ward, Gayathri Sivakumar, Sindu Kanjeekal, Caroline Hamm, Brayden C. Labute, David Shum & John W. Hudson
Pages: 2123-2133
Published online: 24 Jan 2015
AbstractforThe deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies | Full Text | References | PDF (1.1 MB) | Supplemental
  • 403 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo
Niklas Vogt, Dmitriy Abramov, Karoline Koch, Neus Masqué-Soler, Monika Szczepanowski & Wolfram Klapper
Pages: 2134-2140
Published online: 14 Nov 2014
AbstractforNo evidence of cell cycle dysregulation in mantle cell lymphoma in vivo | Full Text | References | PDF (3 MB) | Supplemental
  • 172 Views
  • 2 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations
So Yamada, Yasuo Ishida, Akira Matsuno & Kazuto Yamazaki
Pages: 2141-2145
Published online: 14 Jan 2015
AbstractforPrimary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations | Full Text | References | PDF (168.4 KB) | Supplemental
  • 909 Views
  • 65 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in “double hit” lymphoma cells
Nadine Johnson-Farley, Jonny Veliz, S. Bhagavathi & Joseph R. Bertino
Pages: 2146-2152
Published online: 28 Jan 2015
AbstractforABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in “double hit” lymphoma cells | Full Text | References | PDF (1.7 MB) | Supplemental
  • 1234 Views
  • 52 CrossRef citations
  • 0Altmetric
Article
Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas
Song He, Yuejiao Huang, Yuchan Wang, Jie Tang, Yan Song, Xiafei Yu, Jing Ma, Shitao Wang, Haibing Yin, Qiuyue Li, Lili Ji & Xiaohong Xu
Pages: 2153-2161
Published online: 27 Jan 2015
AbstractforHistamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas | Full Text | References | PDF (2.9 MB) | Supplemental
  • 290 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells
Xuan Zhou, Na Xu, Rong Li, Yajuan Xiao, Guanlun Gao, Qisi Lu, Li Ding, Ling Li, Yuling Li, Qingfeng Du & Xiaoli Liu
Pages: 2162-2169
Published online: 14 Jan 2015
AbstractforA comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells | Full Text | References | PDF (1.5 MB) | Supplemental
  • 318 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr–Abl-induced transformation and leukemogenesis
Bo Zuo, Mei Li, Yulan Liu, Kun Li, Shuyun Ma, Meihua Cui, Yazhen Qin, Honghu Zhu, Xiuying Pan, Jingzhu Guo, Zonghan Dai & Weidong Yu
Pages: 2170-2181
Published online: 04 Dec 2014
AbstractforG-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr–Abl-induced transformation and leukemogenesis | Full Text | References | PDF (6.6 MB) | Supplemental
  • 236 Views
  • 10 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Monoclonal B-lymphocytosis in patients aged over 90 years is common but not inevitable, and has a prevalence comparable to that in individuals aged 65–90 years
Asha Soosapilla, Dominic Pepperell, Giles Best, Carmela Brizzi, Christopher S. Mulligan, Nenna van Bilsen & Stephen P. Mulligan
Pages: 2182-2184
Published online: 17 Feb 2015
First Page PreviewforMonoclonal B-lymphocytosis in patients aged over 90 years is common but not inevitable, and has a prevalence comparable to that in individuals aged 65–90 years | Full Text | References | PDF (128.6 KB) | Supplemental
  • 89 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma
Kah-Lok Chan, Robin Filshie, Harshal Nandurkar & Hang Quach
Pages: 2185-2186
Published online: 07 Feb 2015
CitationforThrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma | Full Text | References | PDF (277.6 KB) | Supplemental
  • 344 Views
  • 19 CrossRef citations
  • 0Altmetric
Letter
Spontaneous remission in a patient with follicular lymphoma carrying T cell-rich neoplastic follicles and a new complex variant translocation of t(14;18): t(5;14;18)(p15;q32;q21.3)
Masayuki Kato, Yu Uemura, Kazuyuki Sato, Yuka Tsuruoka, Satoshi Yokoi, Yuji Nishio, Tasuku Saito, Manabu Matunawa, Yoshinori Suzuki, Yasushi Isobe, Hirotaka Sakai, Yasuyuki Inoue, Masahiro Hoshikawa, Naoya Nakamura, Masatomo Takahashi & Ikuo Miura
Pages: 2187-2189
Published online: 21 Jan 2015
First Page PreviewforSpontaneous remission in a patient with follicular lymphoma carrying T cell-rich neoplastic follicles and a new complex variant translocation of t(14;18): t(5;14;18)(p15;q32;q21.3) | Full Text | References | PDF (3.1 MB) | Supplemental
  • 134 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Flow cytometry for detection of central nervous system disease in acute myeloid leukemia
Marc Sorigué, Jordi Juncà, Juan-Manuel Sancho, Mireia Morgades, Dani Esteban, Jose-Tomas Navarro, Susana Vives, Evarist Feliu & Josep-Maria Ribera
Pages: 2190-2192
Published online: 06 Mar 2015
First Page PreviewforFlow cytometry for detection of central nervous system disease in acute myeloid leukemia | Full Text | References | PDF (187 KB) | Supplemental
  • 152 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Risk factors for tumor lysis syndrome in childhood acute myeloid leukemia treated with a uniform protocol without rasburicase prophylaxis
Kenji Kishimoto, Ryoji Kobayashi, Mizuho Ichikawa, Hirozumi Sano, Daisuke Suzuki, Kazue Yasuda, Akihiro Iguchi & Kunihiko Kobayashi
Pages: 2193-2195
Published online: 21 Jan 2015
First Page PreviewforRisk factors for tumor lysis syndrome in childhood acute myeloid leukemia treated with a uniform protocol without rasburicase prophylaxis | Full Text | References | PDF (122.3 KB) | Supplemental
  • 245 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Mixed fields on RhD typing as an indication of loss of heterozygosity on chromosome 1p in acute myeloid leukemia
Signy Chow, Jacob Pendergrast, Gorka Ochoa-Garay, Vikas Gupta, Muhammad Ejaz Munir, Kenneth J. Craddock, Cuihong Wei, Suzanne Kamel-Reid & Christine M. Cserti-Gazdewich
Pages: 2196-2199
Published online: 14 Jan 2015
First Page PreviewforMixed fields on RhD typing as an indication of loss of heterozygosity on chromosome 1p in acute myeloid leukemia | Full Text | References | PDF (487.9 KB) | Supplemental
  • 173 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
C3aR1 gene overexpressed at initial stage of acute myeloid leukemia-M2 predicting short-term survival
Shui-yan Wu, Junjie Fan, Dan Hong, Qi Zhou, Defei Zheng, Dong Wu, Zheng Li, Rui-hua Chen, Ye Zhao, Jian Pan, Xiaofei Qi, Chien-shing Chen & Shao-yan Hu
Pages: 2200-2202
Published online: 28 Jan 2015
First Page PreviewforC3aR1 gene overexpressed at initial stage of acute myeloid leukemia-M2 predicting short-term survival | Full Text | References | PDF (416.9 KB) | Supplemental
  • 190 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Very late relapse of Philadelphia chromosome positive acute megakaryoblastic leukemia
Jeffery M. Patterson, Lauren Bolster, Loree Larratt, Marlene Hamilton & Joseph Brandwein
Pages: 2203-2205
Published online: 21 Jan 2015
First Page PreviewforVery late relapse of Philadelphia chromosome positive acute megakaryoblastic leukemia | Full Text | References | PDF (240.9 KB) | Supplemental
  • 94 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront
Massimo Breccia, Matteo Molica, Gioia Colafigli, Irene Zacheo, Roberto Latagliata, Agostino Tafuri & Giuliana Alimena
Pages: 2206-2207
Published online: 09 Feb 2015
CitationforCorrelation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront | Full Text | References | PDF (120 KB) | Supplemental
  • 172 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
A novel chemosensitivity profiling platform for small acute lymphoblastic leukemia cell populations
Line Groth-Pedersen, Yen-Hsi Chen, Marianne Faber, Rebecca Valentin, Birgitte Klug Albertsen, Peder Skov Wehner, Steen Rosthøj, Thomas Leth Frandsen, Hanne Vibeke Marquart & Kjeld Schmiegelow
Pages: 2208-2211
Published online: 21 Jan 2015
First Page PreviewforA novel chemosensitivity profiling platform for small acute lymphoblastic leukemia cell populations | Full Text | References | PDF (361.9 KB) | Supplemental
  • 166 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland
Agnieszka Jatczak-Gaca, Jan Styczynski, Andrzej Koltan, Robert Debski, Monika Pogorzala & Mariusz Wysocki
Pages: 2212-2214
Published online: 09 Feb 2015
First Page PreviewforResults of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland | Full Text | References | PDF (210.3 KB) | Supplemental
  • 56 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Disseminated sclerotic bone lesions with normal 18F-fluorodeoxyglucose uptake in polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome
Xiaofeng Shi, Zhongyi Yang, Lili Wu, Shudong Hu, Qian Jiang, Rong Ba, Qin Zhuang, Xianqiu Yu, Lixia Wang, Xiaodong Xi, Yingjian Zhang & Yan Zhu
Pages: 2215-2217
Published online: 04 Jan 2015
First Page PreviewforDisseminated sclerotic bone lesions with normal 18F-fluorodeoxyglucose uptake in polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome | Full Text | References | PDF (522.9 KB) | Supplemental
  • 71 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma
Jianliang Yang, Yuankai Shi, Xiaohui He, Mei Dong, Changgong Zhang, Peng Liu, Shengyu Zhou, Yan Qin, Lin Gui, Sheng Yang & Yan Sun
Pages: 2218-2221
Published online: 11 Feb 2015
First Page PreviewforA pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma | Full Text | References | PDF (131.9 KB) | Supplemental
  • 179 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
An uncomplicated pregnancy in a woman with smoldering Waldenström macroglobulinemia
Kirsty Rady, Euan Wallace & John F. Seymour
Pages: 2222-2224
Published online: 02 Mar 2015
First Page PreviewforAn uncomplicated pregnancy in a woman with smoldering Waldenström macroglobulinemia | Full Text | References | PDF (124.7 KB) | Supplemental
  • 133 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma
Brittany O’Neill Dulmage, Sara K. Story, Louis D. Falo Jr & Larisa J. Geskin
Pages: 2225-2227
Published online: 21 Jan 2015
First Page PreviewforNovel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma | Full Text | References | PDF (447.8 KB) | Supplemental
  • 235 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles